Unknown NA INTERVENTIONAL 1-arm NCT01152593

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Sponsor: Hillel Yaffe Medical Center

Conditions Cesarean Section Staphylococcus Aureus Surgical Wound Infection

Interventions Mupirocin

Updated 5 times since 2017 Last updated: Jun 28, 2010 Started: Jul 31, 2010 Primary completion: Jul 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01152593, this NA trial focuses on Cesarean Section and Staphylococcus Aureus and remains ongoing. Sponsored by Hillel Yaffe Medical Center, it has been updated 5 times since 2010, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hillel Yaffe Medical Center

Data source: Hillel Yaffe Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hadera, Israel